BTIG Research Increases HealthEquity (NASDAQ:HQY) Price Target to $130.00

HealthEquity (NASDAQ:HQY) had its price objective boosted by analysts at BTIG Research from $110.00 to $130.00 in a report released on Thursday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. BTIG Research’s price objective points to a potential upside of 33.73% from the company’s previous close.

A number of other equities analysts also recently weighed in on HQY. Barrington Research reissued an “outperform” rating and set a $105.00 target price on shares of HealthEquity in a research note on Friday, September 20th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $92.00 target price on shares of HealthEquity in a research note on Wednesday, September 4th. JMP Securities reissued a “market outperform” rating and issued a $105.00 price target on shares of HealthEquity in a research note on Wednesday, September 4th. Deutsche Bank Aktiengesellschaft raised their price objective on shares of HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a research report on Wednesday, September 4th. Finally, Bank of America boosted their target price on shares of HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research report on Wednesday. Twelve research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $107.17.

HealthEquity Trading Up 2.5 %

HQY traded up $2.41 during trading on Thursday, reaching $97.21. 229,381 shares of the company’s stock were exchanged, compared to its average volume of 614,078. The company has a current ratio of 4.10, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51. HealthEquity has a one year low of $62.10 and a one year high of $101.17. The firm has a fifty day moving average price of $84.24 and a two-hundred day moving average price of $80.84. The stock has a market capitalization of $8.49 billion, a PE ratio of 80.70, a price-to-earnings-growth ratio of 1.57 and a beta of 0.52.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.16. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. The business had revenue of $299.93 million during the quarter, compared to analyst estimates of $284.48 million. As a group, equities research analysts forecast that HealthEquity will post 2.27 earnings per share for the current fiscal year.

Insider Activity

In related news, Director Frank Corvino sold 1,039 shares of the firm’s stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $96.10, for a total transaction of $99,847.90. Following the transaction, the director now directly owns 3,784 shares of the company’s stock, valued at $363,642.40. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other HealthEquity news, Director Frank Corvino sold 1,039 shares of the business’s stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total value of $99,847.90. Following the transaction, the director now owns 3,784 shares of the company’s stock, valued at approximately $363,642.40. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Robert W. Selander sold 8,250 shares of the firm’s stock in a transaction on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total value of $684,585.00. Following the sale, the director now directly owns 54,719 shares of the company’s stock, valued at approximately $4,540,582.62. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 10,536 shares of company stock worth $884,517 over the last 90 days. 2.20% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the stock. Raymond James Trust N.A. lifted its stake in HealthEquity by 4.8% in the third quarter. Raymond James Trust N.A. now owns 2,905 shares of the company’s stock valued at $238,000 after purchasing an additional 132 shares during the last quarter. Truist Financial Corp lifted its position in shares of HealthEquity by 7.0% during the 2nd quarter. Truist Financial Corp now owns 2,864 shares of the company’s stock valued at $247,000 after buying an additional 188 shares during the last quarter. O Shaughnessy Asset Management LLC increased its holdings in HealthEquity by 3.9% in the 1st quarter. O Shaughnessy Asset Management LLC now owns 5,219 shares of the company’s stock worth $426,000 after acquiring an additional 197 shares during the last quarter. Nisa Investment Advisors LLC raised its stake in HealthEquity by 7.5% in the 2nd quarter. Nisa Investment Advisors LLC now owns 2,854 shares of the company’s stock valued at $246,000 after acquiring an additional 198 shares during the period. Finally, Elk River Wealth Management LLC raised its stake in HealthEquity by 0.3% in the 3rd quarter. Elk River Wealth Management LLC now owns 66,181 shares of the company’s stock valued at $5,417,000 after acquiring an additional 217 shares during the period. 99.55% of the stock is owned by institutional investors.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.